15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Sensus Healthcare Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $4.00 to $6.00, a moderate spread. The average target of $5.00 sits 56% above the current $3.20. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.02 next quarter toward $-0.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Sensus Healthcare Inc.
As of Sep, 2 of 2 firms rate SRTS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SRTS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.02
Range $-0.04 – $0.01 · 3 analysts · -88% YoY
Next period, 3 analysts expect Sensus Healthcare Inc to earn $-0.02 a share (range $-0.04 – $0.01), versus $-0.19 a year earlier. Full-year consensus is $-0.76, growing to $-0.17 the year after.
REVENUE · NEXT QUARTER
$6.8M
Range $4.6M – $7.8M · 3 analysts · +38% YoY
Revenue is expected to reach $6.8M (range $4.6M – $7.8M), +38.2% year-over-year. Full-year consensus is $19.1M, rising to $28.2M next year.
Top analysts covering Sensus Healthcare Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SRTS.
#1
Yi Chen
HC Wainwright & Co. · Rank #277
Buy
$8.00+150.0% to target
Overall win rate
33%
+ Follow
#2
JW
Jason Wittes
Roth MKM · Rank #311
Buy
$10.00+212.5% to target
Overall win rate
39%
+ Follow
#3
Anthony Vendetti
Maxim Group · Rank #335
Buy
$6.00+87.5% to target
Overall win rate
30%
+ Follow
#4
BH
Ben Haynor
Lake Street
Buy
$4.00+25.0% to target
Coverage
—
+ Follow
#5
SH
Scott Henry
Alliance Global Partners
Buy
$6.50+103.1% to target
Coverage
—
+ Follow
SRTS stock forecast FAQ
What is SRTS's average 12-month price target?+
The 2 analysts with a live target average $5.00 for Sensus Healthcare Inc over the next 12 months, ranging from a $6.00 high to a $4.00 low.
Is SRTS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SRTS?+
The Street-high target is $6.00 (Maxim Group), and the Street-low is $4.00 (Lake Street). The average of all 2 active targets is $5.00.
How many Wall Street analysts cover SRTS?+
2 analysts have an active rating on Sensus Healthcare Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering SRTS?+
Among analysts who currently cover SRTS, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #277). Their current call is Buy with a $8.00 target.
What is Sensus Healthcare Inc's projected EPS for next quarter?+
The consensus estimate is $-0.02 per share (range $-0.04 – $0.01) across 3 analysts. Full-year EPS is projected at $-0.76, rising to $-0.17 the following year.
How much revenue is Sensus Healthcare Inc expected to report next quarter?+
Consensus revenue is $6.8M (range $4.6M – $7.8M). Full-year revenue is projected at $19.1M, growing to $28.2M next year.
Have analysts been upgrading or downgrading SRTS lately?+
As of Sep, 2 of 2 firms rate SRTS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SRTS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
